Re: Russell E.N. Becker, Alexa R. Meyer, Aaron Brant, et al. Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.07.016

Eur Urol. 2021 Feb;79(2):e56-e57. doi: 10.1016/j.eururo.2020.11.007. Epub 2020 Nov 18.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Male
  • Muscles
  • Neoadjuvant Therapy
  • Prostatic Neoplasms*
  • Urinary Bladder Neoplasms* / drug therapy